Evolv Technologies Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share (Tables)

Net Loss per Share (Tables)

3 Months Ended

Mar. 31, 2023

Schedule of basic and diluted net income (loss) per share

Basic and diluted net loss per share attributable to common stockholders was calculated as follows (in thousands, except share and per share amounts):


	Three Months Ended March 31,
	2023		2022
Numerator:







Net income (loss) attributable to common stockholders – basic and diluted	$	(28,609)	$	(13,801)

Denominator:











Weighted average common shares outstanding - basic and diluted	146,433,378		142,878,406
Net loss per share attributable to common stockholders – basic and diluted	$	(0.20)	$	(0.10)

Schedule of potential common shares excluded from the computation of diluted net loss per share

The following potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period:


	Three Months Ended March 31,
	2023	2022
Options issued and outstanding	23,136,658	21,964,309
Public Warrants to purchase common stock	14,324,994	14,324,993



Warrants to purchase common stock (Finback)**	1,590,984	2,421,200
Unvested restricted stock units	12,395,533	6,251,002
Unvested performance stock units	414,500	934,000
Earn-out shares*	15,000,000	15,000,000
Contingently issuable common stock*	1,897,500	1,897,500

	68,760,169	62,793,004

*Issuance of Earn-out shares and Contingently issuable common stock are contingent upon the satisfaction of certain conditions, which were not satisfied by the end of the period

**Includes 79,677 vested warrants and 1,511,307 unvested warrants as of March 31, 2023